689 related articles for article (PubMed ID: 20339029)
1. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21.
Shields JD; Kourtis IC; Tomei AA; Roberts JM; Swartz MA
Science; 2010 May; 328(5979):749-52. PubMed ID: 20339029
[TBL] [Abstract][Full Text] [Related]
2. Immunology. Tumor immune evasion.
Zindl CL; Chaplin DD
Science; 2010 May; 328(5979):697-8. PubMed ID: 20448171
[No Abstract] [Full Text] [Related]
3. CCL-21 conditioned regulatory T cells induce allotolerance through enhanced homing to lymphoid tissue.
Chauhan SK; Saban DR; Dohlman TH; Dana R
J Immunol; 2014 Jan; 192(2):817-23. PubMed ID: 24337379
[TBL] [Abstract][Full Text] [Related]
4. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.
Luther SA; Bidgol A; Hargreaves DC; Schmidt A; Xu Y; Paniyadi J; Matloubian M; Cyster JG
J Immunol; 2002 Jul; 169(1):424-33. PubMed ID: 12077273
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of CCL21 chemokine function by transgenic over-expression impairs T cell immunity to local infections.
Unsoeld H; Mueller K; Schleicher U; Bogdan C; Zwirner J; Voehringer D; Pircher H
Int Immunol; 2007 Nov; 19(11):1281-9. PubMed ID: 17914120
[TBL] [Abstract][Full Text] [Related]
6. CCL21-Ser expression in melanoma cells recruits CCR7
Miyamoto M; Kawato Y; Fujie R; Kurowarabe K; Fujiwara K; Nobusawa R; Hayashi R; Iida K; Ohigashi I; Hayasaka H
Cancer Sci; 2023 Sep; 114(9):3509-3522. PubMed ID: 37421165
[TBL] [Abstract][Full Text] [Related]
7. Disrupted lymph node and splenic stroma in mice with induced inflammatory melanomas is associated with impaired recruitment of T and dendritic cells.
Soudja SM; Henri S; Mello M; Chasson L; Mas A; Wehbe M; Auphan-Anezin N; Leserman L; Van den Eynde B; Schmitt-Verhulst AM
PLoS One; 2011; 6(7):e22639. PubMed ID: 21811640
[TBL] [Abstract][Full Text] [Related]
8. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.
Takeuchi H; Fujimoto A; Tanaka M; Yamano T; Hsueh E; Hoon DS
Clin Cancer Res; 2004 Apr; 10(7):2351-8. PubMed ID: 15073111
[TBL] [Abstract][Full Text] [Related]
9. Central Nervous System Stromal Cells Control Local CD8(+) T Cell Responses during Virus-Induced Neuroinflammation.
Cupovic J; Onder L; Gil-Cruz C; Weiler E; Caviezel-Firner S; Perez-Shibayama C; Rülicke T; Bechmann I; Ludewig B
Immunity; 2016 Mar; 44(3):622-633. PubMed ID: 26921107
[TBL] [Abstract][Full Text] [Related]
10. Lymph node stromal cells strongly influence immune response suppression.
Buettner M; Pabst R; Bode U
Eur J Immunol; 2011 Mar; 41(3):624-33. PubMed ID: 21246540
[TBL] [Abstract][Full Text] [Related]
11. A novel approach to improve immune effector responses post transplant by restoration of CCL21 expression.
Stefanski HE; Jonart L; Goren E; Mulé JJ; Blazar BR
PLoS One; 2018; 13(4):e0193461. PubMed ID: 29617362
[TBL] [Abstract][Full Text] [Related]
12. CCR7 signaling inhibits T cell proliferation.
Ziegler E; Oberbarnscheidt M; Bulfone-Paus S; Förster R; Kunzendorf U; Krautwald S
J Immunol; 2007 Nov; 179(10):6485-93. PubMed ID: 17982037
[TBL] [Abstract][Full Text] [Related]
13. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
14. Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.
Weitzenfeld P; Kossover O; Körner C; Meshel T; Wiemann S; Seliktar D; Legler DF; Ben-Baruch A
J Leukoc Biol; 2016 Jun; 99(6):1009-25. PubMed ID: 26936935
[TBL] [Abstract][Full Text] [Related]
15. Nurselike cells sequester B cells in disorganized lymph nodes in chronic lymphocytic leukemia via alternative production of CCL21.
Zaaboub R; Vimeux L; Contremoulins V; Cymbalista F; Lévy V; Donnadieu E; Varin-Blank N; Martin A; Dondi E
Blood Adv; 2022 Aug; 6(16):4691-4704. PubMed ID: 35679464
[TBL] [Abstract][Full Text] [Related]
16. Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization.
Tejchman A; Lamerant-Fayel N; Jacquinet JC; Bielawska-Pohl A; Mleczko-Sanecka K; Grillon C; Chouaib S; Ugorski M; Kieda C
Oncotarget; 2017 May; 8(19):31876-31887. PubMed ID: 28416768
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues.
Lo JC; Chin RK; Lee Y; Kang HS; Wang Y; Weinstock JV; Banks T; Ware CF; Franzoso G; Fu YX
J Clin Invest; 2003 Nov; 112(10):1495-505. PubMed ID: 14617751
[TBL] [Abstract][Full Text] [Related]
18. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
Tutunea-Fatan E; Majumder M; Xin X; Lala PK
Mol Cancer; 2015 Feb; 14():35. PubMed ID: 25744065
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.
Yamano T; Kaneda Y; Huang S; Hiramatsu SH; Hoon DS
Mol Ther; 2006 Jan; 13(1):194-202. PubMed ID: 16112911
[TBL] [Abstract][Full Text] [Related]
20. Role of lymph node stroma and microenvironment in T cell tolerance.
Saxena V; Li L; Paluskievicz C; Kasinath V; Bean A; Abdi R; Jewell CM; Bromberg JS
Immunol Rev; 2019 Nov; 292(1):9-23. PubMed ID: 31538349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
